Detalhe da pesquisa
1.
Proteins in Tumor-Derived Plasma Extracellular Vesicles Indicate Tumor Origin.
Mol Cell Proteomics
; 22(1): 100476, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36470535
2.
Diptoindonesin G is a middle domain HSP90 modulator for cancer treatment.
J Biol Chem
; 298(12): 102700, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36395883
3.
Co-clinical FDG-PET radiomic signature in predicting response to neoadjuvant chemotherapy in triple-negative breast cancer.
Eur J Nucl Med Mol Imaging
; 49(2): 550-562, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34328530
4.
RON signalling promotes therapeutic resistance in ESR1 mutant breast cancer.
Br J Cancer
; 124(1): 191-206, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33257837
5.
Regulated Phosphosignaling Associated with Breast Cancer Subtypes and Druggability.
Mol Cell Proteomics
; 18(8): 1630-1650, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31196969
6.
Folate Receptor α-Targeted 89Zr-M9346A Immuno-PET for Image-Guided Intervention with Mirvetuximab Soravtansine in Triple-Negative Breast Cancer.
Mol Pharm
; 16(9): 3996-4006, 2019 09 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31369274
7.
Identifying biomarkers of breast cancer micrometastatic disease in bone marrow using a patient-derived xenograft mouse model.
Breast Cancer Res
; 20(1): 2, 2018 01 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29291741
8.
QuantFusion: Novel Unified Methodology for Enhanced Coverage and Precision in Quantifying Global Proteomic Changes in Whole Tissues.
Mol Cell Proteomics
; 15(2): 740-51, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26598639
9.
Integrated Bottom-Up and Top-Down Proteomics of Patient-Derived Breast Tumor Xenografts.
Mol Cell Proteomics
; 15(1): 45-56, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26503891
10.
An Analysis of the Sensitivity of Proteogenomic Mapping of Somatic Mutations and Novel Splicing Events in Cancer.
Mol Cell Proteomics
; 15(3): 1060-71, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26631509
11.
Quality Assessments of Long-Term Quantitative Proteomic Analysis of Breast Cancer Xenograft Tissues.
J Proteome Res
; 16(12): 4523-4530, 2017 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29124938
12.
Patient-derived xenograft (PDX) models in basic and translational breast cancer research.
Cancer Metastasis Rev
; 35(4): 547-573, 2016 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-28025748
13.
Correction to: Coclinical FDGPET radiomic signature in predicting response to neoadjuvant chemotherapy in triplenegative breast cancer.
Eur J Nucl Med Mol Imaging
; 49(2): 788, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-34550428
14.
Reproducibility of Differential Proteomic Technologies in CPTAC Fractionated Xenografts.
J Proteome Res
; 15(3): 691-706, 2016 Mar 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-26653538
15.
Genome remodelling in a basal-like breast cancer metastasis and xenograft.
Nature
; 464(7291): 999-1005, 2010 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-20393555
16.
Ischemia in tumors induces early and sustained phosphorylation changes in stress kinase pathways but does not affect global protein levels.
Mol Cell Proteomics
; 13(7): 1690-704, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24719451
17.
Comprehensive quantitative analysis of ovarian and breast cancer tumor peptidomes.
J Proteome Res
; 14(1): 422-33, 2015 Jan 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-25350482
18.
Evaluation of copanlisib in combination with eribulin in triple negative breast cancer patient-derived xenograft models.
Cancer Res Commun
; 2024 May 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38717161
19.
Crizotinib induces Par-4 secretion from normal cells and GRP78 expression on the cancer cell surface for selective tumor growth inhibition.
Am J Cancer Res
; 13(3): 976-991, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37034206
20.
Breast Cancer Mutations HER2V777L and PIK3CAH1047R Activate the p21-CDK4/6-Cyclin D1 Axis to Drive Tumorigenesis and Drug Resistance.
Cancer Res
; 83(17): 2839-2857, 2023 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37272756